CoLucid Pharmaceuticals to Present at Two Investor Conferences in September

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. NTNX
9. HPQ
10. WDAY

September 3, 2015 8:01 AM EDT

CAMBRIDGE, Mass., Sept. 3, 2015 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD) today announced that Thomas P. Mathers, Chief Executive Officer, will provide a corporate overview at two investor conferences in September.

Rodman & Renshaw 17th Annual Global Investment Conference
Date: Thursday, September 10
Time: 11:15am Eastern Time
Location: St. Regis Hotel, Library Room (2nd Floor)
  New York City
   
Ladenburg Thalmann 2015 Healthcare Conference
Date: Tuesday, September 29
Time: 9:30am Eastern Time
Location: Sofitel New York Hotel, Odeon room
  New York City
Webcast: The presentation will be webcast live on CoLucid's Investor Relations website at http://www.colucid.com/investor_relations

About CoLucid Pharmaceuticals, Inc.

CoLucid was founded in 2005 and is developing oral lasmiditan for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of unspecified headache pain in adults in emergency room and other urgent care settings.

CONTACT: Thomas Mathers
         Chief Executive Officer
         CoLucid Pharmaceuticals, Inc.
         (781) 365-2596

         Hans Vitzthum
         Managing Director
         LifeSci Advisors, LLC.
         (212) 915-2568
Source: CoLucid Pharmaceuticals, Inc

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Ladenburg Thalmann Financial Services